155 related articles for article (PubMed ID: 8013790)
1. Barrett's esophagus: the biology of neoplastic progression.
Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
[No Abstract] [Full Text] [Related]
2. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].
Robaszkiewicz M; Hardy E; Volant A
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D35-9. PubMed ID: 8013781
[No Abstract] [Full Text] [Related]
3. Progression to cancer in Barrett's esophagus is associated with genomic instability.
Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
5. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
[TBL] [Abstract][Full Text] [Related]
6. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus.
Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Teijgeman R; Mulder AH; Bosman FT; van Dekken H
Cancer Res; 1995 May; 55(9):1971-6. PubMed ID: 7728767
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 in Barrett's oesophagus.
Krishnadath KK; van Blankenstein M; Tilanus HW
Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):81-4. PubMed ID: 7866817
[TBL] [Abstract][Full Text] [Related]
9. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ
Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566
[TBL] [Abstract][Full Text] [Related]
10. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma.
Fein M
Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229
[No Abstract] [Full Text] [Related]
11. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS
Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316
[TBL] [Abstract][Full Text] [Related]
12. [Changes in the TP53 tumor suppressor gene in malignant transformation of Barrett esophagus].
Ferec C; Audrezet MP; Mercier B; Robaszkiewicz M
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D46-51. PubMed ID: 8013783
[No Abstract] [Full Text] [Related]
13. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
14. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
Sanz-Ortega J; Hernández S; Saez MC; Sierra E; Sanz-Ortega G; Torres A; Balibrea JL; Sanz-Esponera J; Merino MJ
Hepatogastroenterology; 2003; 50(50):404-7. PubMed ID: 12749233
[TBL] [Abstract][Full Text] [Related]
15. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
16. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.
Blount PL; Ramel S; Raskind WH; Haggitt RC; Sanchez CA; Dean PJ; Rabinovitch PS; Reid BJ
Cancer Res; 1991 Oct; 51(20):5482-6. PubMed ID: 1680552
[TBL] [Abstract][Full Text] [Related]
17. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: a model of human neoplastic progression.
Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
[No Abstract] [Full Text] [Related]
19. Chromosomal instability in Barrett's esophagus is related to telomere shortening.
Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; Li X; Self SG; Gollahon KA; Blount PL; Rabinovitch PS
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1451-7. PubMed ID: 16896031
[TBL] [Abstract][Full Text] [Related]
20. [Molecular alterations in Barrett's esophagus and adenocarcinoma].
Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):235-9. PubMed ID: 10379532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]